Simplex Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,000
| Closed | -$10K | – | 10174 |
|
|
2023
Q4 | $10K | Buy |
+2,000
| New | +$19.7K | ﹤0.01% | 7481 |
|
|
2023
Q1 | – | Sell |
-400
| Closed | -$11K | – | 10394 |
|
|
2022
Q4 | $11K | Buy |
+400
| New | +$12.7K | ﹤0.01% | 7491 |
|
|
2022
Q2 | – | Sell |
-500
| Closed | -$24K | – | 11377 |
|
|
2022
Q1 | $24K | Sell |
500
-3,200
| -86% | -$154K | ﹤0.01% | 8060 |
|
|
2021
Q4 | $188K | Buy |
+3,700
| New | +$192K | ﹤0.01% | 5293 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | -$33K | – | 9237 |
|
|
2020
Q3 | $33K | Buy |
8
+1
| +14% | +$44 | ﹤0.01% | 5999 |
|
|
2020
Q2 | $33K | Buy |
7
+6
| +600% | +$299 | ﹤0.01% | 5859 |
|
|
2020
Q1 | $4K | Sell |
1
-842
| -100% | -$42.3K | ﹤0.01% | 6997 |
|
|
2019
Q4 | $5.06M | Buy |
843
+487
| +137% | +$29K | 0.01% | 792 |
|
|
2019
Q3 | $2.01M | Sell |
356
-164
| -32% | -$9.22K | 0.01% | 1333 |
|
|
2019
Q2 | $2.9M | Buy |
520
+242
| +87% | +$12.6K | 0.01% | 1030 |
|
|
2019
Q1 | $1.4M | Buy |
278
+239
| +613% | +$10.6K | ﹤0.01% | 1691 |
|
|
2018
Q4 | $157K | Sell |
39
-468
| -92% | -$24.1K | ﹤0.01% | 3406 |
|
|
2018
Q3 | $3.52M | Buy |
507
+167
| +49% | +$12.7K | 0.01% | 834 |
|
|
2018
Q2 | $2.57M | Buy |
340
+131
| +63% | +$8.24K | 0.01% | 964 |
|
|
2018
Q1 | $3K | Buy |
209
+129
| +161% | +$7.5K | ﹤0.01% | 5079 |
|
|
2017
Q4 | $11K | Sell |
80
-21
| -21% | -$1.17K | ﹤0.01% | 3840 |
|
|
2017
Q3 | $51K | Sell |
101
-53
| -34% | -$3.21K | ﹤0.01% | 2289 |
|
|
2017
Q2 | $44K | Buy |
154
+123
| +397% | +$10.1K | ﹤0.01% | 2515 |
|
|
2017
Q1 | $35K | Sell |
31
-46
| -60% | -$3.42K | ﹤0.01% | 2703 |
|
|
2016
Q4 | $98K | Sell |
77
-152
| -66% | -$11K | 0.01% | 1551 |
|
|
2016
Q3 | $216K | Sell |
229
-3
| -1% | -$166 | 0.01% | 984 |
|
|
2016
Q2 | $50K | Buy |
232
+139
| +149% | +$5.79K | ﹤0.01% | 2062 |
|
|
2016
Q1 | $63K | Buy |
93
+82
| +745% | +$5.2K | 0.01% | 1753 |
|
|
2015
Q4 | $4K | Sell |
11
-49
| -82% | -$3.87K | ﹤0.01% | 4085 |
|
|
2015
Q3 | $26K | Buy |
60
+57
| +1,900% | +$4.74K | ﹤0.01% | 2554 |
|
|
2015
Q2 | $1K | Buy |
+3
| New | +$195 | ﹤0.01% | 4846 |
|
Other funds holding EGRX
Simplex Trading's EGRX Position: Q1 2025 in Review
Simplex Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2025, closing a stake of 18,162 shares — an estimated $9K sold.
Simplex Trading first reported a position in EGRX in Q2 2015 and held it in 16 quarters. The position peaked at $1.02M in Q1 2020. 2 funds tracked by Wall St. Rank hold EGRX as of Q1 2025.
- Simplex Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 18,162 Eagle Pharmaceuticals, Inc. shares in Q1 2025, an estimated $9K.
- Simplex Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
- Simplex Trading's Eagle Pharmaceuticals, Inc. position peaked at $1.02M in Q1 2020.
- 2 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.